Similar to VBIV and BCDA.
Like mice are similar to elephants in that both have 4 legs, UHD? :-)
Please try forgive the sarcasm. I am quite well aware of the plain fact few investors in scientific R&D know or care much about the science with that being particularly true of shorts.
Aside from VBIV's glioblastoma cancer vaccine with dim prospects in my unresearched opinion, the pair are not remotely like the Israeli biotech hoping to find a cure [cure, not treatment] for nonsense diseases like the many varieties of muscular dystrophy.
All nonsense diseases [name derived from antisense lingo that is a classification of catastrophic diseases resulting from incomplete DNA] are very rare but I think cystic fibrosis is the most common and most devastating, maybe because of a cousin in Ireland who had the disease.
Ignoring my own bias, surely any sentient beings interested in news of even the tabloid variety would have had trouble missing the excitement caused by a dubious treatment for a single variety of muscular dystrophy.
Well yeah, but will Eloxx, the new Sevion if all goes according to plan, cure any nonsense diseases?
- Most likely not given grim statistical odds but the odds themselves are dubious in such a case.
Just some dull thoughts for you more thrilled by chewing the rag. :-)
Best, Terry
News 
Market Data 
Discover 
